Teleflex Inc
NYSE:TFX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Teleflex Inc
Free Cash Flow
Teleflex Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Teleflex Inc
NYSE:TFX
|
Free Cash Flow
$245.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Free Cash Flow
$3.7B
|
CAGR 3-Years
57%
|
CAGR 5-Years
30%
|
CAGR 10-Years
35%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Free Cash Flow
$1.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
Stryker Corp
NYSE:SYK
|
Free Cash Flow
$4.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Free Cash Flow
$7.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
15%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Free Cash Flow
$2.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
Teleflex Inc
Glance View
In the world of medical technology, Teleflex Inc. emerges as a nuanced, multifaceted player, crafting a narrative not just of survival, but of steady growth through innovation and strategic vision. Founded in the allure of post-war optimism in 1943, Teleflex began its journey in the aerospace and marine industries. However, recognizing the steadily aging global population and increasing healthcare demands, the company pivoted towards the medical sector, a decision that has since defined its contemporary identity. Teleflex now thrives as a diversified global provider of medical technologies designed to improve health and the quality of people's lives. It specializes in critical care and surgical solutions, focusing its efforts on areas like vascular access, anesthesia, respiratory care, and urology, among others. Teleflex Inc. crafts its financial landscape through a robust combination of product innovation, strategic acquisitions, and a strong global footprint. Their revenue streams are primarily derived from selling medical devices and equipment to healthcare providers worldwide. A significant competitive edge lies in its ability to consistently introduce new products that address unmet clinical needs while enhancing patient safety and outcomes. This focus is evident in their Research and Development initiatives, which are integral to maintaining their market position. Moreover, by acquiring companies with complementary technologies and market reach, Teleflex continually broadens its portfolio, navigating the complex and evolving healthcare landscape with finesse and agility. Through these strategic maneuvers, the company ensures a steady flow of revenue that aligns with global healthcare trends and demands.
See Also
What is Teleflex Inc's Free Cash Flow?
Free Cash Flow
245.4m
USD
Based on the financial report for Dec 31, 2025, Teleflex Inc's Free Cash Flow amounts to 245.4m USD.
What is Teleflex Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
0%
Over the last year, the Free Cash Flow growth was -55%. The average annual Free Cash Flow growth rates for Teleflex Inc have been -2% over the past three years , -7% over the past five years .